Original | Odaily Planet Daily (@OdailyChina)

Author | Wenser (@wenser 2010)

In the gradually warming cryptocurrency market, the once "Desci Pathlight" - BIO has also delivered an impressive performance: On May 3, the price briefly broke $0.066, staging a doubling act within three days. As we are less than a year and a half away from the DeSci (Decentralized Science) boom at the end of 2024, Bio Protocol, once adorned with the halo of the "Binance Launchpool project," has followed the trend of the AI era, shouting the slogan "Agent Pays for Science." Whether it's old trees blooming or lifting to sell off, perhaps we will soon see the answer.

New and Old Narratives of Bio Protocol: From DeSci to Agentic Desci

Counting the reasons for BIO's price surge, in my view, the most important factor is its new narrative that aligns with the AI era - from decentralized scientific research to AI Agent and agent-driven decentralized scientific research.

This is not only a further refinement of market positioning but also an important step to inject new vitality into the Bio Protocol ecosystem. Specifically, the key actions of Bio Protocol are as follows:

• BioXP System: The BioXP system built on the staking system of Bio Protocol V2, used for priority participation in Ignition Sales (new fundraising), increasing allocation quotas, while accumulating veBIO (governance voting). This is the foundational framework for the long-term construction of the ecosystem.
• Funding Support: In September last year, Bio Protocol completed a $6.9 million seed round, led by Arthur Hayes' Maelstrom Fund, with Mechanism Capital, Animoca Brands, Presto Labs, and others participating, aimed at advancing AI-driven Launchpad and BioAgents; previously, it also received investment from Yzi Labs (formerly Binance Labs). Ample funding is a necessary guarantee for continued construction during bull and bear cycles.
• BioAgent Launchpad: The Launchpad platform built in conjunction with the BioAgents platform focuses on the concept of “allowing anyone to deploy Desci AI agents.” The latest round new project PeptAI launched on May 1, raising 5.9 times the funds in less than 30 minutes, and as of May 4, it has raised 12.7 times (total $633,000, with tokens listed at a fully diluted value of $1 million and a token price of $0.1), with over 700 participants, for 14 days, ending at 9 PM on May 14. Additionally, regarding token distribution: 20% of the total supply of PEPTAI will be airdropped to BIO stakers (veBIO holders, released linearly over 6 months); 5% will be publicly available through Ignition Sale; those without BioXP can directly use BIO to mint or stake to make up. Thus, through the Launchpad new project mechanism, Bio Protocol has formed a positive cycle of "staking BIO tokens → earning BioXP points → participating in project fundraising → participating in community governance."

According to official data, the Bio ecosystem has currently raised over $50 million; the community has around 90,000 members.

In this new flywheel effect, the BIO token has continued its previous upward trend in just three days, surging from about $0.03 to $0.066, currently temporarily retracing to around $0.06.

Of course, updating the narrative and iterating the project is one aspect; on the other hand, the Bio Protocol team’s proactive market-making or lifting to sell off is also another focus of market attention.

Lifting to Sell Off or Proactive Market Making? A Look at the Ambition of the Bio Protocol Team

On the morning of May 3, according to cryptocurrency analyst Ai Aunt @ai_9684xtpa monitoring, BIO rose 118% in the past week. On that day, the Bio Protocol project team transferred 120 million BIO to three addresses from its multi-signature address, with about 80 million transferred to OKX and Binance, worth approximately $5.031 million.

On the other side, Binance had previously announced that it would add BIO/U trading pairs on April 28, 2026, at 16:00 (Beijing time) on the isolated margin leverage, further fueling BIO's increase at the contract level.

Currently, the market value of the BIO token is temporarily reported at $127 million, which is still significantly lower compared to the peak market value of $1.1 billion at the beginning of 2025, and the operations of the Bio Protocol team have not significantly affected the price of BIO. Given the substantial recovery to above $80,000 in the broader cryptocurrency market, the future price of BIO is expected to continue rising.

Additionally, more importantly, the latest new project PEPTAI under the Bio Protocol ecosystem has entered the wet lab experimentation phase, operating in a model of “AI Agent autonomous decision-making + on-chain information transparency,” which to some extent truly pushes the previously more concentrated on concept validation stage of the Desci track into the actual business phase of “replicable drug discovery assembly line.”

From this perspective, the ambition of the Bio Protocol team has never been small. After all, they are leveraging a trillion-dollar medical market segment.

Of course, considering the niche nature of the Desci track and compliance thresholds, in the short term, the price trend of BIO tokens this year still highly depends on concept speculation.

Recommended Reading:

Light of Desci? Understand Binance Launchpool's latest project BIO in one article

免责声明：本文章仅代表作者个人观点，不代表本平台的立场和观点。本文章仅供信息分享，不构成对任何人的任何投资建议。用户与作者之间的任何争议，与本平台无关。如网页中刊载的文章或图片涉及侵权，请提供相关的权利证明和身份证明发送邮件到support@aicoin.com，本平台相关工作人员将会进行核查。